Sulnine

Quick links to important sections

Sulnine

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Sulnine

Property Description
Active ingredient Oxazolam
Form Oral solid forms (Capsules or Tablets)
Pharmacological class Benzodiazepine derivative
Common use Relief of anxiety and tension
Origin Synthetic substance

What is Sulnine and What Type of Drug is It?

Sulnine is a prescription-only medication defined by its single active ingredient, Oxazolam. It is formally classified as a benzodiazepine derivative and belongs to the broader pharmacological group of Central Nervous System (CNS) depressants.

Oxazolam is a synthetic substance that functions as both an anxiolytic (anti-anxiety) and a sedative-hypnotic, placing it within the category of psycholeptics. Oxazolam is a benzodiazepine derivative used to treat states of tension and anxiety. The compound's bioavailability when administered orally is a characteristic of its pharmacological profile.


Composition, Origin, and Available Form

The composition of Sulnine is a single-ingredient product, where the chemical Oxazolam is the sole pharmacologically active component, combined with necessary pharmaceutical excipients. The drug is formulated for oral administration and is typically presented as an oral solid dosage form, available as either a tablet or a capsule. As a man-made compound, its origin is wholly synthetic, relying on precise chemical synthesis rather than natural sources.


What is the General Purpose of Sulnine?

The general purpose of Sulnine is to provide symptomatic relief from states of intense mental and physical agitation by modifying activity in the central nervous system. The compound is recognized for its therapeutic role in promoting calmness.

By enhancing the brain's natural inhibitory mechanisms, the drug promotes a state of mental composure and reduces excessive tension, fulfilling its primary role as an anxiolytic. This action is also associated with secondary skeletal muscle relaxant properties, assisting in the relief of physical tightness often associated with severe restlessness.

What side effects are possible with Sulnine?

Possible Side Effects and Safety Information

The safety profile of Sulnine (Oxazolam), a benzodiazepine derivative, is characterized by the risks associated with the Central Nervous System (CNS) depressant class. The adverse reactions are classified in regulatory documents based on frequency and affected system-organ classes.


Adverse Reactions and Frequency

The most commonly reported adverse reaction is transient mild drowsiness, which is often observed in the initial days of therapy. Other frequently documented CNS effects include dizziness, vertigo, headache, and lethargy. Less common reactions noted in regulatory sources involve the skin (minor diffuse rashes), the gastrointestinal system (nausea), and general disorders (edema). Rare effects include syncope (fainting), leukopenia, and hepatic dysfunction, such as jaundice.


Serious Safety Considerations

Official labeling contains serious warnings regarding the risk of abuse, misuse, addiction, and physical dependence, noting that risk increases with the dose and duration of treatment. Life-threatening adverse outcomes include profound sedation and respiratory depression, particularly when the medicine is used concomitantly with opioids or other CNS depressants. Abrupt discontinuation or rapid dose reduction after continued use can precipitate acute withdrawal reactions, which may include seizures.


Population-Specific Safety Statements

Specific caution is advised for older adults, who may experience increased sensitivity to effects such as sedation and hypotension. Patients with hepatic impairment require careful monitoring due to the potential for slower clearance of the medicine. The label also notes that use during late pregnancy carries a risk of effects on the neonate, including withdrawal syndrome.

Overdose and Emergency Response

Sulnine Overdose and When to Seek Help

Overdose with Sulnine (Oxazolam) is officially documented by regulatory authorities as involving progressive Central Nervous System (CNS) depression. Manifestations may initially include extreme sleepiness, confusion, slurred speech (dysarthria), and ataxia (uncoordinated movements). Severe, life-threatening outcomes requiring immediate medical intervention include profound sedation, respiratory depression, and coma. Regulatory labeling notes that the risk of these severe outcomes, including death, is significantly increased when Sulnine is co-ingested with other CNS depressants, such as alcohol or opioids.

Mandated Emergency Action

Official guidance states that immediate medical attention must be sought. You must contact emergency services immediately if any severe symptom occurs, particularly shallow or slowed breathing or the onset of excessive sleepiness. Management is primarily symptomatic and supportive, involving the maintenance of a patent airway and continuous hospital monitoring of vital signs. While Flumazenil is available as a specific antidote, regulatory caution surrounds its use due to the risk of precipitating acute withdrawal or seizures. Elderly patients are at higher risk of hypotension, and neonates may exhibit respiratory depression following late-pregnancy exposure.

Therapeutic Uses of Sulnine

What Sulnine Treats: Main Uses and Benefits

Sulnine (Oxazolam) is utilized in the management of severe anxiety syndromes and pathological states of tension. It is commonly used across conditions presenting with acute episodes and those characterized by periods of heightened symptoms that create noticeable interference with daily stability.

The medication's primary use is to provide supportive relief from symptoms of excessive worry, fear, mental agitation, and physical tightness. It is also applied in acute clinical settings, such as during the initial phases of sudden alcohol withdrawal. This medication contributes to easing the overall symptom load during difficult episodes.

Supportive Relief for Anxiety-Driven Muscle Tightness

This supportive relief is helpful in situations where symptoms become temporarily overwhelming, assisting with the maintenance of functional stability and contributing to improved comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Sulnine?

Eligibility for Sulnine (Oxazolam) is strictly defined by regulatory documents, distinguishing between populations that may use the medicine and those where use is absolutely prohibited or restricted.

Contraindicated Populations

Use of Sulnine is strictly prohibited for patients with a known hypersensitivity to the drug, as well as those with myasthenia gravis, severe respiratory insufficiency, severe hepatic insufficiency, sleep apnea syndrome, or acute narrow-angle glaucoma.

Age and Developmental Status

The medication is approved for use in adults (18 to 65 years). Use is generally not recommended in children and adolescents, as safety and efficacy have not been established for the anxiety indication in these groups. Older adults are eligible but require restricted use and often a lower initial dose due to increased sensitivity.

Furthermore, Sulnine is generally not recommended for women who are pregnant or breastfeeding.

Condition-Based Restrictions

Eligibility is conditional for individuals with a history of alcohol or drug dependence, requiring strict supervision. Caution is also mandated for patients with depression, COPD, renal impairment, or moderate hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions involving Sulnine (Oxazolam), a benzodiazepine derivative, are classified based on officially documented effects on the central nervous system (CNS) and metabolic clearance. All information is derived from regulatory drug labels.


Documented Interaction Patterns

Co-administration with Opioid Analgesics and other CNS Depressants (including antipsychotics and antihistamines) results in a highly significant additive pharmacodynamic effect. This effect is formally documented to increase the risk of profound sedation and respiratory depression.

Oxazolam metabolism is subject to pharmacokinetic alteration primarily mediated by the Cytochrome P450 3A (CYP3A) enzyme pathway. Substances that inhibit CYP3A are documented to increase the plasma concentration (exposure) of Sulnine by reducing its clearance. Conversely, substances that induce CYP3A are documented to reduce Oxazolam exposure.


Interaction Restrictions and Specific Substances

Co-administration with strong CYP3A inhibitors is formally listed as a contraindicated combination in regulatory labeling. The consumption of alcohol (ethanol) must be strictly avoided due to its severe additive CNS depressant effects. Furthermore, the herbal product St John’s Wort is documented as a CYP3A inducer that may reduce drug effectiveness. Population-specific notes document that elderly and debilitated patients may exhibit increased sensitivity to these combined CNS depressant effects.

Mechanism of Action

Selective Inhibition of the NaV1.8 Sodium Channel

Sulnine acts as a highly selective inhibitor of the NaV1.8 voltage-gated sodium channel, a membrane protein predominantly expressed in peripheral sensory nerve fibers. This interaction stabilizes the channel in a closed, inactivated state, which physically blocks the channel’s pore. The consequence of this molecular binding is the prevention of the rapid influx of sodium ions (Na^+) that is essential for initiating a regenerative electrical impulse, or action potential.


Modulating Peripheral Sensory Signaling

By targeting this ion channel, Sulnine affects the peripheral somatosensory pathway, decreasing the electrical excitability of the targeted nerve fibers outside the central nervous system. This peripheral action results in a constraint on the transfer of repetitive nerve impulses from the periphery toward the spinal cord and brain. The mechanism dictates the signal-carrying capacity of the NaV1.8 channel, thereby modulating the overall afferent sensory input at the level of the peripheral nerve and determining the downstream physiological effect on nerve signal processing.

Dosage and Administration Information

How Sulnine is Used: Official Administration Guidelines

Sulnine (Oxazolam) is administered exclusively via the oral route as a capsule or tablet. The medication is generally intended for short-term use, typically not exceeding four months of continuous administration.

Standard Dosing and Frequency

The dosage for Sulnine is typically administered in divided doses multiple times throughout the day to ensure consistent presence. This means the medicine is usually taken three or four times daily, according to the prescribed regimen. The dose range varies based on the severity of the condition being managed:

  • Mild-to-Moderate Anxiety: Doses usually range from 10 mg to 15 mg per dose.
  • Severe Anxiety or Agitation: Doses commonly range from 15 mg to 30 mg per dose.

Administration Context and Adjustments

Sulnine can be taken with or without food. Specific considerations apply to certain patient groups. For older adults, a lower starting dose is usually prescribed, often beginning at 10 mg taken three times daily, which may be adjusted if necessary. Use in children under six years of age is not recommended.

Due to the nature of the medication, abrupt discontinuation after extended use is avoided. A gradual reduction of the dose is standard practice when therapy is concluded to minimize the risk of withdrawal symptoms. The continued need for the medication is also subject to periodic reassessment.

Recent Clinical Evidence

Research evidence / Overview of studies for Sulnine

Evidence Explored in Severe Anxiety Syndromes and Tension States

Research concerning Sulnine primarily involved short-term, placebo-controlled randomized controlled trials (RCTs). These studies were conducted using adult populations and aimed to determine how symptoms change over time in studies where Sulnine was administered. The main study outcomes involved measurements on standardized assessment tools, such as the Hamilton Anxiety Rating Scale (HAM-A), which is used in studies examining patient-reported experiences of tension and fear.

The trials reported that, during the defined study periods, changes were measured in anxiety scale scores when compared against placebo administration. Studies reported patterns of symptomatic change, particularly for outcomes related to physical discomfort often associated with high anxiety. Findings reported a recurring pattern across numerous short-term trials examining symptom intensity or variability.

Evidence Explored in Acute Clinical Settings (Alcohol Withdrawal)

Sulnine was evaluated in comparative clinical trials conducted during acute episodes where symptoms become more noticeable, such as managing severe symptoms during alcohol withdrawal. Research examined adult patients in clinical settings experiencing outcomes describing episodic or acute changes. Studies monitored specific physiological strain or stress markers and used scales like the Clinical Institute Withdrawal Assessment for Alcohol (CIWA) to track symptom severity.

Studies report how symptoms evolved in the observed populations during the short detoxification phase (usually 3 to 10 days). Findings describe patterns where the administration of Sulnine was associated with the observation of changes in measured acute, severe withdrawal symptoms. The evidence derived from settings with varying symptom burdens is highly specific to the acute management phase.

What Research Gaps and Uncertainties Remain in the Evidence

The available research contributes to the broader evidence landscape regarding short-term measured symptom changes, but several key limitations remain. There is limited information for long-term outcomes regarding both the durability of measured symptomatic change and the chronic effects of administration. Comparative evidence is lacking against the full spectrum of modern, non-benzodiazepine treatments now available. Additionally, findings reflect group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. NIH MedlinePlus Drug Information: Benzodiazepines (General class mechanism and use overview)
  2. WHO Anatomical Therapeutic Chemical (ATC) Classification System - N05BA Benzodiazepine derivatives (Used for pharmacological classification)
  3. Clinical Practice Guideline: Management of severe alcohol withdrawal (Representative national clinical guideline for acute use context)

Frequently Asked Questions (FAQ)

Common questions about Sulnine (FAQ)


Q: Why is Sulnine sometimes mentioned with condition X?

Official product information states that Sulnine is indicated for the management of anxiety disorders and for the relief of anxiety symptoms that may be associated with depression. It is also approved for the management of symptoms during acute alcohol withdrawal. The authorized uses are strictly defined by regulatory agencies.


Q: Is it normal to have mild stomach upset when starting Sulnine?

Regulatory documents list nausea as an adverse reaction that has been reported. While the most common side effects like drowsiness are generally transient (meaning they fade after initial use), if any gastrointestinal symptoms are concerning or persistent, consulting a healthcare professional is recommended.


Q: Can Sulnine cause changes in my mood or thinking?

Yes, the official warnings state that monitoring is recommended for patients experiencing new or worsening feelings of anxiety, depression, or other unusual changes in mood or behavior. Other serious mental side effects, such as sudden confusion or hallucinations, have also been reported on the label.


Q: Are there any common foods or drinks that should be avoided with Sulnine?

Official regulatory labeling mandates that the consumption of alcohol be strictly avoided because of the high risk of severe additive Central Nervous System (CNS) depressant effects. According to the regulatory documents, there are no known formal interactions between Sulnine and general foods or non-alcoholic drinks.


Q: Can Sulnine be taken with pain relievers like ibuprofen?

Official warnings focus on the high risk of combined use with opioid analgesics and other medications that slow down the central nervous system (CNS) depressants). Non-opioid, over-the-counter pain relievers are not specifically listed as a formal interaction in the regulatory labeling. It is important that all prescription and over-the-counter medicines used are reviewed with a healthcare professional.


Q: Does Sulnine have a warning about driving or operating machinery?

Yes, official patient counseling information advises that Sulnine can cause side effects like drowsiness, dizziness, or weakness. Regulatory information advises against driving a car or operating dangerous machinery, as the medication may impair judgment or physical coordination.


Q: Does Sulnine affect energy levels?

The official list of common side effects includes both drowsiness and lethargy. These Central Nervous System (CNS) depressant effects are generally associated with a noticeable reduction in energy levels.


Q: How quickly does Sulnine usually start to work?

Studies on the drug's activity indicate that the onset of action is generally considered slow. The effects typically begin to be noticed between 30 and 120 minutes after taking the medication.


Q: Is Sulnine a controlled substance?

Yes, Sulnine (Oxazolam) is classified as a Schedule IV controlled substance by regulatory bodies such as the U.S. Drug Enforcement Administration (DEA). This classification indicates that the drug has an approved medical use but carries a potential for abuse or dependence.


Q: How long does Sulnine stay in your system after you stop taking it?

The active ingredient's elimination is described by its half-life, which typically ranges from 6 to 9 hours. This is the time it takes for half the amount of the drug to be cleared from the body.


Q: Does Sulnine affect the way birth control pills work?

Regulatory labeling indicates that the drug is metabolized by the CYP3A enzyme pathway in the liver. However, there is no specific documented warning or formal interaction listed for the use of oral contraceptives (birth control pills).


Q: Why is my blood pressure mentioned when I am prescribed Sulnine?

Regulatory documentation notes that Sulnine can cause low blood pressure (hypotension) as a side effect. This risk is specifically highlighted as a concern, particularly in older adults, who may be more sensitive to this effect.


Q: What are the main things to discuss with a healthcare provider before starting Sulnine?

Regulatory sources emphasize the importance of discussing all existing medical conditions—especially a history of substance abuse, depression, or liver/kidney disease. A thorough review of all other current medicines and supplements is required by the regulatory labeling, particularly any CNS depressants or opioids.


Q: Does taking Sulnine affect lab test results?

Yes, the active ingredient belongs to the benzodiazepine drug class, which is included in some standardized urine or blood drug tests. The presence of the drug or its metabolites may be detected.


Q: Is it true that Sulnine can cause sensitivity to sunlight?

No, photosensitivity (increased sensitivity to sunlight) is not listed as a documented adverse reaction in the regulatory documents covering Sulnine.


Q: What are the signs of a serious reaction to Sulnine?

Signs of a serious reaction can include the sudden swelling of the face, lips, tongue, or throat, trouble swallowing, hives, or difficulty breathing. Other serious symptoms include seizures and profound sedation, which are symptoms that warrant prompt medical consultation.

How should Sulnine be stored and disposed of?

How to Store and Dispose of Sulnine?

The official regulatory labeling requires that Sulnine (Oxazolam) be stored at Controlled Room Temperature, which ranges from 20 C to 25 C (68 F to 77 F). The product must be protected from excessive moisture, humidity, and must not be frozen.

Storage Requirements Summary Condition Rule
Temperature Controlled Room Temperature (20 C–25 C)
Container Store in the original, tightly closed container
Safety Keep strictly out of the sight and reach of children

Disposal must adhere to pharmaceutical waste guidelines. Unused or expired Sulnine should be handled through an authorized drug take-back program or disposed of according to local household instructions. It is explicitly required not to flush this medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sulnine found in:

A-Z Index: